CoED Biosciences

CoED Biosciences is a biotech developing the Column of Expansion and Differentiation (CoED) platform, a consumable device integrating immune cell separation, functionalisation, and expansion in a single workflow.

The system exploits the natural migratory behaviour of immune cells across membranes, replacing centrifuge-based methods to produce purer, more viable cells with organ-specific targeting capability.

Designed for CAR-T and other adoptive cell therapies, the platform targets the cost and complexity barriers limiting patient access to cancer immunotherapies.